Medical Oncology

General Gastroenterology

Questions discussed in this category

Are there any adverse risk factors in stage I colon cancer that would warrant ctDNA testing?

If a stage I colon cancer had positive ctDNA after surgery, what treatment, if any, would you recommend and for how long?

4 Answers available

Papers discussed in this category

JAMA network open, 2024 Dec 02

Circulating Tumor DNA Testing in Curatively Resected Colorectal Cancer and Salvage Resection.

N Engl J Med, 2022 Jun 04

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.

Nature medicine, 2024 Sep 16

ctDNA-based molecular residual disease and survival in resectable colorectal cancer.

JAMA oncology, 2019-05-09

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer.

JAMA oncology, 2019-05-09

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.

Cancers (Basel), 2020 Sep 29

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review.

Canadian journal of surgery. Journal canadien de chirurgie, 2019 Oct 01

Tumour budding predicts increased recurrence after curative resection for T2N0 colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology, 2019 Nov 01

Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.

Frontiers in oncology, 2022 Dec 14

Post-operative ctDNA monitoring in stage I colon cancer: A case report.

Related Topics in Medical Oncology